Syngene focuses on innovating R&D services

Syngene focuses on innovating R&D services
Syngene International, a subsidiary of the biopharma major, Biocon, is a leading player in custom research.

Syngene International Private Limited (Syngene) along with its clinical services arm has clocked revenues of Rs 224.60 crore in fiscal year 2008-09 as against Rs 160 crore in 2007-08.
Syngene conducts high value R&D in early stage drug discovery and development for a diverse global clientele. From early stage discovery and process development through to cGMP manufacturing, Syngene provides customized R&D services to pharmaceutical and biotechnology companies on a strong platform of confidentiality and intellectual property protection. Established in 1994, Syngene was India’s first custom research organization to receive special export status by the Government of India. Over the past 14 years, the company has successfully partnered with leading players in the global pharmaceutical industry across a range of challenging programs, from discovery to supply of complex development compounds.
Syngene, since inception, has developed skills in synthetic chemistry and molecular biology, process chemistry and cell line services. The company is also leveraging the convergence of IT and biotech. In 2007, Syngene entered into a research partnership with Bristol-Myers Squibb (BMS). Through this partnership, the company provides R&D services for discovery and early drug development to BMS. In same partnership Syngene opened a fully-dedicated research and development facility for Bristol-Myers Squibb in Biocon Park, Bangalore. The 2,00,000 sq.ft. facility at Biocon Park, dedicated to help advance Bristol Myers Squibb’s work in discovery and early drug development, is currently occupied by 270 scientists.
The facility will house 360 scientists by the end of the year and could accommodate as many as 450 scientists in future.
In another development, Syngene International has deepened its relationship with DuPont Crop Protection and signed up as its alliance partner. The company will now cover a broad range of R&D technical capabilities to support DuPont’s discovery pipeline. Already a research service provider to DuPont in discovery chemistry and biology, Syngene will now provide integrated research services through its One Box model.